期刊文献+

siRNA抑制S100A4表达对卵巢癌细胞CP70生物学特性的影响 被引量:2

Effects of S100A4 Gene Silienced by S100A4 SiRNA on Cisplatin Sensitivity, Apoptosis and Migration of Ovarian Cancer Cell Line CP70
原文传递
导出
摘要 目的:探讨人卵巢癌顺铂耐药细胞株CP70沉默S100A4基因后,CP70细胞对顺铂敏感性、凋亡及细胞迁移的影响。方法:设计并合成S100A4基因特异性的siRNA并转染入卵巢癌细胞CP70,48 h后应用RT-PCR和Western Blot检测在mRNA和蛋白水平siRNA对S100A4的影响,MTT法检测转染siRNA后卵巢癌细胞CP70对顺铂敏感性的变化。用流式细胞术检测顺铂(40μM)对转染S100A4 siRNA后对卵巢癌细胞CP70凋亡的影响,Transwell法观察siRNA抑制S100A4后对卵巢癌CP70迁移能力的影响。结果:与空白对照组、阴性对照组相比,S100A4siRNA转染组CP70细胞的S100A4基因和蛋白表达降低(P<0.01)。MTT法检测顺铂敏感性发现S100A4 siRNA转染组CP70细胞顺铂敏感性增强。在顺铂刺激下,siRNA转染组细胞凋亡率高于其他各组,差异具有统计学意义(P<0.05)。Transwell发现CP70细胞迁移能力明显下降(P<0.05)。结论:S100A4 siRNA能够明显抑制CP70细胞S100A4的表达,从而增强细胞对顺铂的敏感性,促进细胞凋亡,减弱细胞的迁移能力。S100A4有望成为逆转卵巢癌铂类耐药的治疗靶点。 Objective: To observe the effect of silencing the expression of S100A4 on the cisplatin sensitivity, apoptosis and migration in cisplatin resistance cell line CP70. Methods: The S100A4 siRNA was constructed and then transfected into CP70. After 48 h, RT-PCR and Western blot were used to detect the inhibition effect of S100A4. MTT assay was performed to evaluate the effect of S100A4 gene silence on cisplatin sensitivity of CP70. The apoptosis rates were detected by using flow cytometry. Results: Compared with blank control group and negative control group,the expressions of S100A4 mRNA and protein were inhibited significantly in CP70 cells(P〈0.01) after transfecting with S100A siRNA for 48 h.MTT assay found that down-regulation of S100A4 enhanced cisplatin sensitivity in CP70. The apoptosis rate of siRNA transfection group induced by cisplatin was higher than other groups, respectively(P〈0. 05). Cell migration ability was reduced in siRNA transfection group(P〈0.01). Conclusion: S100A4 siRNA can significantly enhanced the cisplatin sensitivity and inhibited migration ability of CP70.S100A4 can be the target of reversing the resistance to chemotherapy in ovarian cancer.
出处 《现代生物医学进展》 CAS 2014年第13期2401-2404,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81172460/M162)
关键词 S100A4 小分子干扰RNA 卵巢癌 顺铂 耐药 S100A4 siRNA Ovarian cancer Cisplatin Drug resistance
  • 相关文献

参考文献21

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics,2010 [J]. CA Cancer J Clin,2010,60(5):277-300.
  • 2Cannistra SA. Cancer of the ovary [J]. N Engl J Med, 2004,351 (24): 2519-2529.
  • 3Fu X, Tian J, Zhang L, et al. Involvement of mieroRNA-93,a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells[J]. FEBS Lett, 2012,586(9):1279-1286.
  • 4Han, L.Y., E. Kipps, and S.B. Kaye. Current treatment and clinical trials in ovarian cancer[J]. Expert Opin Investig Drugs, 2010,19(4): 521-534.
  • 5Li Z H, Dulyaninova N G, House R P, et al. S100A4 regulates macrophage chemotaxis[J]. Mol Biol Cell,2010,21 (15):2598-2610.
  • 6Emberley E D, Murphy L C, Waston P H. S100 proteins and their influence on pro-survival pathways in cance [J]. r.Biochem Cell Biol, 2004,82(4):508-515.
  • 7GarrettS C, Vamey K M, Weber K, et al. S100A4,a mediator of metastasis[J]. Biol Chem,2006,281 (2):677-680.
  • 8Feng L Z, Zheng X Y, Zhou L X, et al. Correlation between expression of S100A4 and VEGF-C,and lymph node metastasis and prognosis in gastric carcinoma[J]. Int Med Res,2011,39(4)1333-1343.
  • 9高静,辛晓燕,张颖.S100A4与卵巢癌细胞顺铂耐药相关性的研究[J].现代妇产科进展,2012,21(4):255-258. 被引量:1
  • 10Boulikas T,Vougiouka M.Ciplatin and platinum drugs at the molecular level.(Review)[J]. Oncol Rep,2003,10(6): 1663-1682.

二级参考文献10

  • 1Chobanian N,Dietrich CR.Ovarian cancer[J].Surg ClinNorth Am,2008,88(2):285-299.
  • 2Garrett SC,Varney KM,Weber DJ,et al.S100A4,a medi-ator of metastasis[J].J Biol Chem,2006,281(2):677-680.
  • 3Malashkevich VN,Varney KM,Garrett SC,et al.Structureof Ca2+-bound S100A4 and its interaction with peptidesderived from nonmuscle myosin-ⅡA[J].Biochemistry,2008,47(18):5111-5126.
  • 4Tarabykina S,Griffiths TR,Tulchinsky E,et al.Metasta-sis-associated protein S100A4:spotlight on its role in cellmigration[J].Curr Cancer Drug Targets,2007,7(3):217-228.
  • 5Helfman DM,Kim EJ,Lukanidin E,et al.The metastasisassociated protein S100A4:role in tumour progression andmetastasis[J].Br J Cancer,2005,92(11):1955-1958.
  • 6Schafer BW,Heizmann CW.The S100 family of EF-handcalcium-binding proteins:functions and pathology[J].Trends Biochem Sci,1996,21(4):134-140.
  • 7Maelandsmo GM,Florenes VA,Nguyen MT,et al.Differ-ent expression and clinical role of S100A4 in serous ovari-an carcinoma at different anatomic sites[J].Tumour Bi-ol,2009,30(1):15-25.
  • 8Mueller A,Bachi T,Hochli M,et al.Subcellular distribu-tion of S100 proteins in tumor cells and their relocation inresponse to calcium activation[J].Histochem Cell Biol,1999,111(6):453-459.
  • 9Ambartsumian N,Klingelhofer J,Grigorian M,et al.Themetastasis-associated Mts1(S100A4)protein could act asan angiogenic factor[J].Oncogene,2001,20(34):4685-4695.
  • 10钱秀艳,张淑兰.S100A4蛋白在妇科恶性肿瘤中的研究进展[J].国际妇产科学杂志,2010,37(2):108-111. 被引量:7

同被引文献23

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部